🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

U.S. reaches 322 million doses of COVID-19 vaccine administered : CDC

Published 06/26/2021, 02:19 PM
Updated 06/26/2021, 02:20 PM
© Reuters. FILE PHOTO: A teenager is inoculated with Pfizer's vaccine against coronavirus disease (COVID-19) after Georgia authorized the vaccine for ages over 12 years, at Dekalb Pediatric Center in Decatur, Georgia, U.S. May 11, 2021.   REUTERS/Chris Aluka Berry
JNJ
-
MRNA
-

(Reuters) - The United States has administered 322,123,103 doses of COVID-19 vaccines in the country as of Saturday morning, and distributed 381,276,030 doses, the U.S. Centers for Disease Control and Prevention (CDC) said on Saturday.

Those figures are up from the 321,199,379 vaccine doses the CDC said had gone into arms by June 25 out of 380,222,670 doses delivered.

© Reuters. FILE PHOTO: A teenager is inoculated with Pfizer's vaccine against coronavirus disease (COVID-19) after Georgia authorized the vaccine for ages over 12 years, at Dekalb Pediatric Center in Decatur, Georgia, U.S. May 11, 2021.   REUTERS/Chris Aluka Berry

The agency said 178,873,816 people had received at least one shot, while 152,184,243 in the United States are fully vaccinated as of Saturday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6:00 a.m. ET on Saturday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.